Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Renal Cell 65Sarcoma 40Neoplasm Metastasis 22Neoplasms 20Ovarian Neoplasms 17Breast Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Recurrence 7Leiomyosarcoma 7Kidney Neoplasms 7Melanoma 6Liposarcoma 6Hemangiosarcoma 6Glioblastoma 6Fallopian Tube Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Neurofibrosarcoma 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Solid Tumors 4Sarcoma, Synovial 4Pancreatic Neoplasms 4Osteosarcoma 4Histiocytoma, Malignant Fibrous 4Dermatofibrosarcoma 4Clear-cell metastatic renal cell carcinoma 4Chondrosarcoma, Extraskeletal Myxoid 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3

Interventions

Manual Lymphatic Drainage 11Exercise 11Low-Level Light Therapy 6Standard of Care 4Radiotherapy 4Physical Therapy Modalities 4Exercise Therapy 4Acupuncture Therapy 4Surveys and Questionnaires 3Resistance Training 3Methods 3Lipectomy 3Indocyanine Green 3Compression Bandages 3pycnogenols 2Yoga 2Technetium Tc 99m Sulfur Colloid 2Restraint, Physical 2Pentoxifylline 2Lymph Node Excision 2Ketoprofen 2High-Energy Shock Waves 2Early Intervention, Educational 2Control Groups 2Bupivacaine 2Bevacizumab 2specific substance maruyama 1pirfenidone 1pazopanib 1carbohydrate-deficient transferrin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphedema × pazopanib × Clear all
NCT00827372 2023-10-16

A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer

Indiana University

Phase 2 Completed
10 enrolled 10 charts

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡